Candriam SCA’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.07M | Buy |
+427,342
| New | +$3.07M | 0.02% | 429 |
|
|
2024
Q1 | – | Sell |
-232,487
| Closed | -$1.37M | – | 703 |
|
|
2023
Q4 | $1.37M | Sell |
232,487
-545,000
| -70% | -$3.2M | 0.01% | 542 |
|
|
2023
Q3 | $7.53M | Buy |
777,487
+5,000
| +0.6% | +$48.4K | 0.05% | 261 |
|
|
2023
Q2 | $9.15M | Sell |
772,487
-164,654
| -18% | -$1.95M | 0.07% | 256 |
|
|
2023
Q1 | $9.31M | Sell |
937,141
-60,000
| -6% | -$596K | 0.06% | 267 |
|
|
2022
Q4 | $11.5M | Sell |
997,141
-154,361
| -13% | -$1.78M | 0.08% | 244 |
|
|
2022
Q3 | $17.2M | Sell |
1,151,502
-99,387
| -8% | -$1.48M | 0.12% | 182 |
|
|
2022
Q2 | $11.3M | Sell |
1,250,889
-502,091
| -29% | -$4.53M | 0.09% | 209 |
|
|
2022
Q1 | $13.1M | Sell |
1,752,980
-112,792
| -6% | -$845K | 0.09% | 216 |
|
|
2021
Q4 | $16M | Sell |
1,865,772
-61,477
| -3% | -$527K | 0.1% | 203 |
|
|
2021
Q3 | $16.2M | Buy |
1,927,249
+16,529
| +0.9% | +$139K | 0.11% | 204 |
|
|
2021
Q2 | $15.5M | Buy |
1,910,720
+1,435,911
| +302% | +$11.6M | 0.11% | 224 |
|
|
2021
Q1 | $5.12M | Buy |
474,809
+79
| +0% | +$852 | 0.04% | 369 |
|
|
2020
Q4 | $5.33M | Buy |
+474,730
| New | +$5.33M | 0.04% | 378 |
|